Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors

NCT06927297 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor Malignancies
Advanced Solid Malignancies

Interventions

BIOLOGICAL: Engineered mitochondrial vaccine

Sponsor

West China Hospital